IDT Australia Stock

IDT Australia Equity

The The Equity of IDT Australia (IDT.AX) as of Aug 17, 2026 is 21.89 M AUD. In the previous year, The Equity was 23.44 M AUD — a change of -6.63% (lower).

Equity

21.89 MAUD

YoY

-6.63%

Last updated:

In 2026, IDT Australia's equity was 21.89 M AUD, a -6.63% increase from the 23.44 M AUD equity in the previous year.

Access this data via the Eulerpool API

IDT Australia Stock analysis

What does IDT Australia do? IDT Australia Ltd is a leading company in the development and manufacturing of pharmaceutical active ingredients and other biological products. The company was founded in 1974 and is headquartered in Melbourne, Australia. For over 40 years, IDT has been working to develop innovative solutions and products to improve the health and well-being of people worldwide. The history of IDT Australia Ltd began with the goal of Walter and Elke Kortschak to establish a company that produces high-quality pharmaceutical active ingredients. The company started its active ingredient production in a small facility in Melbourne and was able to grow quickly. In the following years, IDT expanded into various areas of the pharmaceutical industry and is now a leading manufacturer of drugs, vaccines, and diagnostics. IDT Australia Ltd is divided into four main areas: active ingredients, biologics, diagnostics, and vaccines. Each of these areas has unique products and services offered by the company. In the field of active ingredients, IDT Australia Ltd offers a wide range of pharmaceutical active ingredients. The company specializes in the production of API's (Active Pharmaceutical Ingredients) used in the manufacturing of drugs. The product range includes strong painkillers to cancer drugs. IDT also produces custom active ingredients tailored to the specific needs of a customer. In the field of biologics, IDT Australia Ltd specializes in the production of biological products. Here, the company offers an extensive range of products such as antibodies, enzymes, recombinant proteins, and more. These products are used in drug research and development and in diagnostics. The diagnostics sector includes both diagnostic tests and test kits. IDT produces tests for a variety of conditions such as hypertension, diabetes, metabolic disorders, and infectious diseases. The diagnostics division of IDT has become an important part of the company, supporting accurate diagnosis, rapid decision-making, and optimal treatment of diseases. The vaccines sector is one of the newest areas at IDT Australia Ltd. In this field, the company specializes in the production of vaccines against infectious diseases. This means that IDT is one of the few Australian companies with the capability to develop and produce vaccines. The company works closely with the Australian government, private health organizations, and other companies to ensure the development of effective vaccines against serious infectious diseases. IDT Australia Ltd takes pride in offering products and services of the highest quality. The company is committed to meeting the requirements and expectations of its customers—and beyond. From the development of new medications to the production of high-quality active ingredients, biologics, diagnostics, and vaccines, IDT carefully monitors all production processes. The company continually invests in research and development to improve processes and products. The work of IDT Australia Ltd has received countless awards and recognition, both in Australia and internationally. The company is among the ten Australian companies represented in the Global Cleantech 100 in 2017. IDT Australia Ltd also holds the record for the fastest order processing for a medical device in Australia. However, the success of the company is not only measured by its industry and customer recognition, but also by the commitment of its employees to research, innovation, and improved health worldwide. Overall, IDT Australia Ltd plays a significant role in the development and manufacturing of active ingredients, biologics, diagnostics, and vaccines. The products and services of the company have the potential to improve the lives of millions of people worldwide. IDT Australia Ltd is on track to continue being a driving force in the development and production of new products in the pharmaceutical industry. IDT Australia is one of the most popular companies on Eulerpool.

Equity Details

Analyzing IDT Australia's Equity

IDT Australia's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding IDT Australia's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating IDT Australia's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

IDT Australia's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in IDT Australia’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about IDT Australia stock

The Equity of IDT Australia is 21.89 M AUD in 2026.

The Equity of IDT Australia changed from 23.44 M AUD to 21.89 M AUD, representing a -6.63% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of The Equity IDT Australia since 2006 – with annual values, charts, and detailed analysis.

The Equity's AUD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track The Equity's IDT Australia historically and in real time.

Access this data via the Eulerpool API

Balance Sheet — IDT Australia

All Key Metrics — IDT Australia